治疗性血交换:对实践的分析和遵守国际准则的遵守
Davi Mesquita Miranda1, Marina Vilela Pires Coelho1, Márcia Torresan Delamain1,2
1Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.
Journal of clinical apheresis
|April 18, 2025
概括
治疗性血交换 (TPE) 是对自身免疫性疾病和移植排斥的安全有效治疗方法. 这项研究发现TPE与美国阿菲雷西斯协会的指导方针相一致,罕见的不良事件.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 治疗性血交换 (TPE) 是对自身免疫性疾病,血液学紧急情况以及在移植受体中管理抗体相关问题的关键治疗方法.
- 对于TPE,已经有确定的指导方针,比如美国阿菲雷西斯协会 (ASFA) 的指导方针,但现实世界流行病学数据和遵守是必不可少的.
研究的目的:
- 为了分析巴西队列中治疗性血酶的流行病学.
- 评估TPE指示与ASFA指导方针的协调程度.
- 调查与TPE相关的不良事件的发生率和性质.
主要方法:
- 一项回顾性观察性研究分析了从2021年4月到2023年12月的85名患者的493次TPE疗程.
- 收集的数据包括患者人口统计数据,TPE指示,替代液体和不良事件.
- 评估了遵守ASFA指导方针,对程序进行分类.
主要成果:
- 对于TPE最常见的症状是光学神经炎 (24%) 和急性移植排斥 (21%).
- 在5.88%的患者中发生了不良事件,主要是轻度事件,如低血压和血管回应;没有报告死亡.
- TPE程序在很大程度上遵循ASFA指南,50%被归类为I类,并且没有发现不良事件和诊断之间有显著的关联.
结论:
- 治疗性血交换是一种有效和安全的治疗光学神经炎和移植排斥的程序.
- 该研究证实,该队列中的TPE实践与已建立的ASFA指南保持一致.
- 与TPE相关的不良事件是罕见的和可控的,支持其在临床实践中继续使用.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482